You are here

Article Text

Article menu
Download PDFPDF
Miscellanea
Journal club
Indwelling pleural catheters versus chest tube and talc pleurodesis in malignant pleural effusion
  1. E Nuttall
  1. Correspondence to E Nuttall, Respiratory Medicine, ST4, Royal Blackburn Hospital, Haslingden Road, Blackburn BB2 3HH, UK; eknuttall{at}doctors.org.uk

https://doi.org/10.1136/thoraxjnl-2012-202847

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Malignant pleural effusion causes dyspnoea in more than 1 million people annually and current guidelines recommend chest tube insertion and talc slurry as first-line treatment.

    This unblinded randomised controlled trial aimed to determine whether indwelling pleural catheters (IPCs) are more effective at relieving dyspnoea in patients with malignant effusions than chest tube and talc pleurodesis. One hundred and six …

    View Full Text

    Footnotes

      • Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnoea in patients with malignant pleural effusion. The TIME2 randomised controlled trial. JAMA 2012;307:2383–9.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.